WORKSHOP B | 8-11AM

Time: 8:00 am
day: Pre Conference Track B

Details:

Translatable Biomarkers: Measuring Dose & Efficacy in the Clinic

  • Discussing the relevance and specificity of clinical biomarkers and endpoints are currently being used for neurological trials
  • Which gene therapy specific factors need to be accounted for?
  • Are there novel biomarkers being trialled?